{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T04:01:27Z","timestamp":1793073687507,"version":"4.5.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.msard.2024.105843","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T22:29:05Z","timestamp":1724452145000},"page":"105843","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Relapse-Independent disease activity in neuromyelitis optica spectrum disorder: A systematic review"],"prefix":"10.1016","volume":"90","author":[{"given":"Masoud","family":"Etemadifar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyyed-Ali","family":"Alaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Akaishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehri","family":"Salari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9468-1561","authenticated-orcid":false,"given":"Mahdi","family":"Norouzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Samadzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedemann","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2024.105843_bib0001","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jneuroim.2017.10.001","article-title":"Subclinical retinal atrophy in the unaffected fellow eyes of multiple sclerosis and neuromyelitis optica","volume":"313","author":"Akaishi","year":"2017","journal-title":"J. Neuroimmunol."},{"issue":"12","key":"10.1016\/j.msard.2024.105843_bib0002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167473","article-title":"Retinal morphology and sensitivity are primarily impaired in eyes with Neuromyelitis Optica Spectrum Disorder (NMOSD)","volume":"11","author":"Akiba","year":"2016","journal-title":"PLoS. One"},{"issue":"2","key":"10.1016\/j.msard.2024.105843_bib0003","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/WNO.0b013e3182893dd1","article-title":"Subclinical optic neuritis in neuromyelitis optica","volume":"33","author":"Aksoy","year":"2013","journal-title":"J. Neuroophthalmol."},{"issue":"5","key":"10.1016\/j.msard.2024.105843_bib0004","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/ana.26067","article-title":"Serum glial fibrillary acidic protein: a neuromyelitis optica spectrum disorder biomarker","volume":"89","author":"Aktas","year":"2021","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.msard.2024.105843_bib0005","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1177\/13524585211028831","article-title":"Optical coherence tomography angiography indicates subclinical retinal disease in neuromyelitis optica spectrum disorders","volume":"28","author":"Aly","year":"2022","journal-title":"Mult. Scler. Houndmills Basingstoke Engl."},{"issue":"6","key":"10.1016\/j.msard.2024.105843_bib0006","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1177\/1352458514567216","article-title":"Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography","volume":"21","author":"Bennett","year":"2015","journal-title":"Mult. Scler. Houndmills Basingstoke Engl."},{"issue":"10","key":"10.1016\/j.msard.2024.105843_bib0007","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1177\/13524585231188485","article-title":"The effect of smoking on MRI lesion resolution in NMOSD-AQP4 and MOGAD","volume":"29","author":"Berhanu","year":"2023","journal-title":"Mult. Scler. Houndmills Basingstoke Engl."},{"issue":"10","key":"10.1016\/j.msard.2024.105843_bib0008","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1177\/1352458513476562","article-title":"Longitudinal follow-up of vision in a neuromyelitis optica cohort","volume":"19","author":"Bouyon","year":"2013","journal-title":"Mult. Scler. Houndmills Basingstoke Engl."},{"issue":"4","key":"10.1016\/j.msard.2024.105843_bib0009","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.preteyeres.2006.05.003","article-title":"M\u00fcller cells in the healthy and diseased retina","volume":"25","author":"Bringmann","year":"2006","journal-title":"Prog. Retin. Eye Res."},{"issue":"1","key":"10.1016\/j.msard.2024.105843_bib0010","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12974-021-02249-1","article-title":"Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies","volume":"18","author":"Carnero Contentti","year":"2021","journal-title":"J. Neuroinflammation."},{"issue":"10","key":"10.1016\/j.msard.2024.105843_bib0011","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1177\/13524585231187120","article-title":"Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world setting","volume":"29","author":"Carnero Contentti","year":"2023","journal-title":"Mult. Scler. Houndmills Basingstoke Engl."},{"key":"10.1016\/j.msard.2024.105843_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.647618","article-title":"Serum neurofilament light and GFAP are associated with disease severity in inflammatory disorders with aquaporin-4 or myelin oligodendrocyte glycoprotein antibodies","volume":"12","author":"Chang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2024.105843_bib0013","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fneur.2020.00035","article-title":"The detection of retina microvascular density in subclinical aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorders","volume":"11","author":"Chen","year":"2020","journal-title":"Front. Neurol."},{"issue":"18","key":"10.1016\/j.msard.2024.105843_bib0014","doi-asserted-by":"crossref","first-page":"6993","DOI":"10.1523\/JNEUROSCI.23-18-06993.2003","article-title":"Methylprednisolone increases neuronal apoptosis during autoimmune CNS inflammation by inhibition of an endogenous neuroprotective pathway","volume":"23","author":"Diem","year":"2003","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.msard.2024.105843_bib0015","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s12974-016-0746-9","article-title":"Complement-independent retinal pathology produced by intravitreal injection of neuromyelitis optica immunoglobulin G","volume":"13","author":"Felix","year":"2016","journal-title":"J. Neuroinflammation."},{"issue":"11","key":"10.1016\/j.msard.2024.105843_bib0016","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1177\/1352458520977771","article-title":"Evidence of subclinical quantitative retinal layer abnormalities in AQP4-IgG seropositive NMOSD","volume":"27","author":"Filippatou","year":"2021","journal-title":"Mult. Scler. Houndmills Basingstoke Engl."},{"issue":"1","key":"10.1016\/j.msard.2024.105843_bib0017","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1097\/WNO.0000000000001282","article-title":"Optic neuritis-independent retinal atrophy in neuromyelitis optica spectrum disorder","volume":"42","author":"Filippatou","year":"2022","journal-title":"J. Neuro-Ophthalmol. Off. J. North Am. Neuro-Ophthalmol. Soc."},{"issue":"3","key":"10.1016\/j.msard.2024.105843_bib0018","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1212\/NXI.0000000000000034","article-title":"Massive CNS monocytic infiltration at autopsy in an alemtuzumab-treated patient with NMO","volume":"1","author":"Gelfand","year":"2014","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"issue":"9","key":"10.1016\/j.msard.2024.105843_bib0019","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1136\/jnnp.2008.166207","article-title":"Distinctive retinal nerve fibre layer and vascular changes in neuromyelitis optica following optic neuritis","volume":"80","author":"Green","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.msard.2024.105843_bib0020","first-page":"89","article-title":"Retinal ganglion cell-inner plexiform and nerve fiber layers in neuromyelitis optica","volume":"11","author":"Hu","year":"2018","journal-title":"Int. J. Ophthalmol."},{"issue":"6","key":"10.1016\/j.msard.2024.105843_bib0021","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1136\/bjophthalmol-2018-312231","article-title":"Peripapillary and parafoveal vascular network assessment by optical coherence tomography angiography in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders","volume":"103","author":"Huang","year":"2019","journal-title":"Br. J. Ophthalmol."},{"issue":"1\u20132","key":"10.1016\/j.msard.2024.105843_bib0022","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jns.2011.03.038","article-title":"Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures","volume":"306","author":"Jarius","year":"2011","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.msard.2024.105843_bib0023","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41572-020-0214-9","article-title":"Neuromyelitis optica","volume":"6","author":"Jarius","year":"2020","journal-title":"Nat. Rev. Dis. Primer."},{"issue":"4","key":"10.1016\/j.msard.2024.105843_bib0024","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/ene.13266","article-title":"Normal-appearing white matter demyelination in neuromyelitis optica spectrum disorder","volume":"24","author":"Jeong","year":"2017","journal-title":"Eur. J. Neurol."},{"issue":"7","key":"10.1016\/j.msard.2024.105843_bib0025","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s00415-016-8138-8","article-title":"Subclinical primary retinal pathology in neuromyelitis optica spectrum disorder","volume":"263","author":"Jeong","year":"2016","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2024.105843_bib0026","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3988\/jcn.2018.14.2.200","article-title":"Optical coherence tomography versus visual evoked potentials for detecting visual pathway abnormalities in patients with neuromyelitis optica spectrum disorder","volume":"14","author":"Kim","year":"2018","journal-title":"J. Clin. Neurol. Seoul Korea"},{"issue":"7","key":"10.1016\/j.msard.2024.105843_bib0027","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/ene.13321","article-title":"Diffusion tensor imaging of normal-appearing white matter in patients with neuromyelitis optica spectrum disorder and multiple sclerosis","volume":"24","author":"Kim","year":"2017","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2024.105843_bib0028","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00415-023-11910-z","article-title":"Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) \u2013 revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management","volume":"271","author":"K\u00fcmpfel","year":"2024","journal-title":"J. Neurol."},{"issue":"23","key":"10.1016\/j.msard.2024.105843_bib0029","doi-asserted-by":"crossref","first-page":"e3124","DOI":"10.1212\/WNL.0000000000010847","article-title":"Incidence of interattack asymptomatic brain lesions in NMO spectrum disorder","volume":"95","author":"Lee","year":"2020","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.msard.2024.105843_bib0030","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/jnc.15478","article-title":"Serum neurofilament light chain and glial fibrillary acidic protein in AQP4-IgG-seropositive neuromyelitis optica spectrum disorders and multiple sclerosis: a cohort study","volume":"159","author":"Liu","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.msard.2024.105843_bib0031","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.nicl.2016.05.014","article-title":"Quantifying visual pathway axonal and myelin loss in multiple sclerosis and neuromyelitis optica","volume":"11","author":"Manogaran","year":"2016","journal-title":"Neuroimage Clin."},{"issue":"1","key":"10.1016\/j.msard.2024.105843_bib0032","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/jnnp-2021-326386","article-title":"Silent progression of brain atrophy in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder","volume":"93","author":"Masuda","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2024.105843_bib0033","unstructured":"Messina S, Mariano R, Geraldes R, Kim SH, Satukijcha C, Vecchio D, et al. The influence of smoking on the pattern of disability and relapse risk in AQP4-positive neuromyelitis optica spectrum disorder, MOG-Ab disease and multiple sclerosis. [cited 2024 Jun 22]; Available from: https:\/\/www.msard-journal.com\/article\/S2211-0348(21)00039-0\/abstract."},{"key":"10.1016\/j.msard.2024.105843_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.105093","article-title":"Progression independent of relapses in aquaporin4-IgG-seropositive neuromyelitis optica spectrum disorder, myelin oligodendrocyte glycoprotein antibody-associated disease, and multiple sclerosis","volume":"80","author":"Molazadeh","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105843_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577702","article-title":"Evidence for and against subclinical disease activity and progressive disease in MOG antibody disease and neuromyelitis optica spectrum disorder","volume":"360","author":"Molazadeh","year":"2021","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.msard.2024.105843_bib0036","doi-asserted-by":"crossref","first-page":"e805","DOI":"10.1212\/NXI.0000000000000805","article-title":"Altered fovea in AQP4-IgG-seropositive neuromyelitis optica spectrum disorders","volume":"7","author":"Motamedi","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.msard.2024.105843_bib0037","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1523\/JNEUROSCI.17-01-00171.1997","article-title":"Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain","volume":"17","author":"Nielsen","year":"1997","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"issue":"12","key":"10.1016\/j.msard.2024.105843_bib0038","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1136\/jnnp-2018-318382","article-title":"Retinal ganglion cell loss in neuromyelitis optica: a longitudinal study","volume":"89","author":"Oertel","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.msard.2024.105843_bib0039","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1212\/NXI.0000000000000334","article-title":"Microstructural visual system changes in AQP4-antibody\u2013seropositive NMOSD","volume":"4","author":"Oertel","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"issue":"6","key":"10.1016\/j.msard.2024.105843_bib0040","doi-asserted-by":"crossref","first-page":"e1068","DOI":"10.1212\/NXI.0000000000001068","article-title":"Retinal optical coherence tomography in neuromyelitis optica","volume":"8","author":"Oertel","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.msard.2024.105843_bib0041","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4103\/tjo.tjo_22_20","article-title":"Evaluation of retinal nerve fiber layer thickness and optic nerve functions in fellow eye of neuromyelitis optica with unilateral optic neuritis","volume":"10","author":"Ong Chin Feng","year":"2020","journal-title":"Taiwan. J. Ophthalmol."},{"issue":"14","key":"10.1016\/j.msard.2024.105843_bib0042","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1177\/1352458515578888","article-title":"A comparative optical coherence tomography study in neuromyelitis optica spectrum disorder and multiple sclerosis","volume":"21","author":"Outteryck","year":"2015","journal-title":"Mult. Scler. Houndmills Basingstoke Engl."},{"issue":"12","key":"10.1016\/j.msard.2024.105843_bib0043","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.1007\/s00330-016-4282-x","article-title":"Brain parenchymal damage in neuromyelitis optica spectrum disorder \u2013 A multimodal MRI study","volume":"26","author":"Pache","year":"2016","journal-title":"Eur. Radiol."},{"issue":"13","key":"10.1016\/j.msard.2024.105843_bib0044","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1002\/jnr.22437","article-title":"Deletion of aquaporin-4 renders retinal glial cells more susceptible to osmotic stress","volume":"88","author":"Pannicke","year":"2010","journal-title":"J. Neurosci. Res."},{"issue":"6","key":"10.1016\/j.msard.2024.105843_bib0045","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1474-4422(12)70133-3","article-title":"Aquaporin 4 and neuromyelitis optica","volume":"11","author":"Papadopoulos","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2024.105843_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102712","article-title":"Primary progression in NMOSD. Does it really exist?","volume":"48","author":"Parissis","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"12","key":"10.1016\/j.msard.2024.105843_bib0047","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1093\/brain\/awac030","article-title":"Anterior optic pathway pathology in CNS demyelinating diseases","volume":"145","author":"Pisa","year":"2022","journal-title":"Brain J. Neurol."},{"issue":"10","key":"10.1016\/j.msard.2024.105843_bib0048","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1177\/1352458519861603","article-title":"Subclinical neurodegeneration in multiple sclerosis and neuromyelitis optica spectrum disorder revealed by optical coherence tomography","volume":"26","author":"Pisa","year":"2020","journal-title":"Mult. Scler. Houndmills Basingstoke Engl."},{"issue":"1","key":"10.1016\/j.msard.2024.105843_bib0049","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/nyas.12794","article-title":"Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later","volume":"1366","author":"Pittock","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.msard.2024.105843_bib0050","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/1352458515593406","article-title":"Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis","volume":"22","author":"Ramanathan","year":"2016","journal-title":"Mult. Scler. Houndmills Basingstoke Engl."},{"issue":"4","key":"10.1016\/j.msard.2024.105843_bib0051","doi-asserted-by":"crossref","first-page":"e407","DOI":"10.1212\/WNL.0000000000008684","article-title":"Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders","volume":"94","author":"Ringelstein","year":"2020","journal-title":"Neurology."},{"issue":"5","key":"10.1016\/j.msard.2024.105843_bib0052","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1177\/1352458513503053","article-title":"Visual evoked potentials in neuromyelitis optica and its spectrum disorders","volume":"20","author":"Ringelstein","year":"2014","journal-title":"Mult. Scler. Houndmills Basingstoke Engl."},{"issue":"7","key":"10.1016\/j.msard.2024.105843_bib0053","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1111\/ene.14766","article-title":"Foveal changes in aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorder are independent of optic neuritis and not overtly progressive","volume":"28","author":"Roca-Fern\u00e1ndez","year":"2021","journal-title":"Eur. J. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2024.105843_bib0054","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1212\/01.WNL.0000106946.08741.41","article-title":"Magnetization transfer and diffusion tensor MRI show gray matter damage in neuromyelitis optica","volume":"62","author":"Rocca","year":"2004","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.msard.2024.105843_bib0055","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/jim-2019-001126","article-title":"CNS Inflammatory demyelinating disorders: MS, NMOSD and MOG antibody associated disease","volume":"68","author":"Rosenthal","year":"2020","journal-title":"J. Investig. Med."},{"issue":"1","key":"10.1016\/j.msard.2024.105843_bib0056","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12974-021-02138-7","article-title":"Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder","volume":"18","author":"Schindler","year":"2021","journal-title":"J. Neuroinflammation."},{"key":"10.1016\/j.msard.2024.105843_bib0057","article-title":"Differences in advanced magnetic resonance imaging in MOG-IgG and AQP4-IgG seropositive neuromyelitis optica spectrum disorders: a comparative study","volume":"11","author":"Schmidt","year":"2020","journal-title":"Front. Neurol. [Internet]"},{"issue":"12","key":"10.1016\/j.msard.2024.105843_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103465","article-title":"A comprehensive review of the advances in neuromyelitis optica spectrum disorder","volume":"22","author":"Siriratnam","year":"2023","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.msard.2024.105843_bib0059","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejrad.2017.07.002","article-title":"Analysis of brain and spinal cord lesions to occult brain damage in seropositive and seronegative neuromyelitis optica","volume":"94","author":"Sun","year":"2017","journal-title":"Eur. J. Radiol."},{"issue":"5","key":"10.1016\/j.msard.2024.105843_bib0060","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1007\/s00415-015-7674-y","article-title":"The outcome spectrum of multiple sclerosis: disability, mortality, and a cluster of predictors from onset","volume":"262","author":"Tedeholm","year":"2015","journal-title":"J. Neurol."},{"issue":"12","key":"10.1016\/j.msard.2024.105843_bib0061","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1177\/1352458517727604","article-title":"Bidirectional degeneration in the visual pathway in neuromyelitis optica spectrum disorder (NMOSD)","volume":"24","author":"Tian","year":"2018","journal-title":"Mult. Scler. Houndmills Basingstoke Engl."},{"issue":"1","key":"10.1016\/j.msard.2024.105843_bib0062","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0306-4522(93)90473-S","article-title":"The role of M\u00fcller cells in the formation of the blood-retinal barrier","volume":"55","author":"Tout","year":"1993","journal-title":"Neuroscience"},{"issue":"14","key":"10.1016\/j.msard.2024.105843_bib0063","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.3390\/ijms21145021","article-title":"Differential effects of MS therapeutics on B cells\u2014implications for their use and failure in AQP4-positive NMOSD patients","volume":"21","author":"Traub","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.msard.2024.105843_bib0064","doi-asserted-by":"crossref","first-page":"e224","DOI":"10.1212\/NXI.0000000000000224","article-title":"Cervical spinal cord atrophy in NMOSD without a history of myelitis or MRI-visible lesions","volume":"3","author":"Ventura","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"issue":"13","key":"10.1016\/j.msard.2024.105843_bib0065","doi-asserted-by":"crossref","first-page":"e1299","DOI":"10.1212\/WNL.0000000000008160","article-title":"Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD","volume":"93","author":"Watanabe","year":"2019","journal-title":"Neurology."},{"issue":"6","key":"10.1016\/j.msard.2024.105843_bib0066","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/ana.26049","article-title":"Long-term safety and efficacy of eculizumab in aquaporin-4 IgG-positive NMOSD","volume":"89","author":"Wingerchuk","year":"2021","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.msard.2024.105843_bib0067","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.msard.2024.105843_bib0068","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMra1904655","article-title":"Neuromyelitis optica spectrum disorder","volume":"387","author":"Wingerchuk","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.msard.2024.105843_bib0069","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1212\/01.wnl.0000254502.87233.9a","article-title":"A secondary progressive clinical course is uncommon in neuromyelitis optica","volume":"68","author":"Wingerchuk","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2024.105843_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102166","article-title":"Efficacy and safety of monoclonal antibody therapy in neuromyelitis optica spectrum disorders: evidence from randomized controlled trials","volume":"43","author":"Xue","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"6","key":"10.1016\/j.msard.2024.105843_bib0071","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ophtha.2019.01.016","article-title":"Evidence of M\u00fcller glial dysfunction in patients with aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder","volume":"126","author":"You","year":"2019","journal-title":"Ophthalmology."},{"issue":"1","key":"10.1016\/j.msard.2024.105843_bib0072","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1148\/radiol.2461062075","article-title":"Pathogenesis of normal-appearing white matter damage in neuromyelitis optica: diffusion-tensor MR imaging","volume":"246","author":"Yu","year":"2008","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.msard.2024.105843_bib0073","first-page":"1009","article-title":"Diffusion tensor imaging in the assessment of normal-appearing brain tissue damage in relapsing neuromyelitis optica","volume":"27","author":"Yu","year":"2006","journal-title":"Am. J. Neuroradiol."},{"issue":"1","key":"10.1016\/j.msard.2024.105843_bib0074","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s40478-016-0355-y","article-title":"Aquaporin 4-specific T cells and NMO-IgG cause primary retinal damage in experimental NMO\/SD","volume":"4","author":"Zeka","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"issue":"3","key":"10.1016\/j.msard.2024.105843_bib0075","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/bjophthalmol-2020-315842","article-title":"Comparison of macular structural and vascular changes in neuromyelitis optica spectrum disorder and primary open angle glaucoma: a cross-sectional study","volume":"105","author":"Zhang","year":"2021","journal-title":"Br. J. Ophthalmol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824004206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824004206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T07:57:28Z","timestamp":1726387048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034824004206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":75,"alternative-id":["S2211034824004206"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2024.105843","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relapse-Independent disease activity in neuromyelitis optica spectrum disorder: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2024.105843","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105843"}}